12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...

The Town of Leader held its regular council meeting on January 7, with Mayor Aaron Wenzel and Councillors Dustin Heatcoat, ...

Commerce Adviser SK Bashir Uddin has not yet received a copy of the task force report on re-strategising the economy, despite ...

The Saskatchewan Government has announced $6.5 million in funding for the Ronald McDonald House Charities (RMHC). The funding will go towards building Regina's first ever Ronald McDonald House.

Together AI has raised $305 million in its Series B funding round. Self-described as an AI acceleration cloud, Together AI's funding round was led by General Catalyst, and co-led by Prosperity7, with ...

AI-driven transformation in telecom is well underway, with network operators pursuing varied AI strategies to improve both ...

Activist investor Palliser Capital is stepping up a campaign to push Rio Tinto to leave the London market, urging the miner ...